Skip to content

A post market clinical follow-up study with the aneXys ceramys inlay DE

A post market clinical follow-up study with the aneXys ceramys inlay DE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00018809
Enrollment
150
Registered
2019-09-13
Start date
2019-10-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.7 M16.1

Interventions

Group 1: single-arm study. there is no comparison group Prospective observational multicenter case series providing mid- to long-term post-market clinical data on the safety and performance of the an

Sponsors

Mathys Orthopädie GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Participants fulfilling all of the following inclusion criteria are eligible for the study: - Informed consent form (signed by participant and investigator) - Primary implantation - Suffer from primary or secondary osteoarthritis of the hip, femoral head and neck fractures or necrosis of the femoral head. In all cases a stable anchoring of the implant has to be possible. - Age at inclusion: between 18 and 75 years old - Willing to participate in the follow-up examinations mentioned above - Complete recovery is expected

Exclusion criteria

Exclusion criteria: The presence of any one of the following exclusion criteria will lead to exclusion of the participant: - Missing informed consent form (signed by participant and investigator) - Known or suspected non-compliance (e.g. drug or alcohol abuse) - Enrolment of the investigator, his/her family, employees and other dependent persons - Patients younger 18 years old - Revision surgery - Presence of sepsis or malignant tumours - ASA (American Society of Anesthesiologists) Classification >3 - Pregnancy

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be the occurrence of noise 2 years after surgery.

Secondary

MeasureTime frame
The secondary endpoint will be the determination of the clinical outcome using the HHS (Harris Hip Score), the VAS for pain and satisfaction.

Countries

Germany

Contacts

Public ContactNatividad Zeleny

Mathys Orthopädie Gmbh

natividad.zeleny@enovis.com+49 (0)1705722702

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026